Abstract
Colorectal cancer is formed and developed through a multi-factor and multi-stage complex pathological process. The review provides an overview of the available colorectal cancer treatments and makes the case for the need to develop specific colon cancer therapeutic products that are safe and stable, with significant therapeutic efficacy and minimal patient sacrifice. The author reviews the progress made in the field of miRNA, nanomedicine system, epidermal growth factor receptor (EGFR), doxorubicin (DOX), dexmedetomidine (DEX) and peptides in the treatment of cancer and point out that more and more researchers are focusing on the treatment of cancer at the genetic level and on the combination of multiple approaches to treat cancer. This review provides an important theoretical reference for the development of multifunctional drugs for the multi-treatment targeting of colorectal cancer.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call